Phase I/II study to determine Safety and Pharmacokinetics of subcutaneous administration of potent and broad anti HIV-1 neutralizing monoclonal antibodies (bNAb), given to HIV-1 exposed…
Comments closedMonth: July 2024
The PedMAb protocol has been accepted for publication in the BMC Infectious Diseases under the title: “Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing…
Comments closed